MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer. The Company’s European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California.
- ConfirmMDx is a non-invasive tissue test to improve the early detection of men at risk for clinically significant prostate cancer immediately following a cancer-negative biopsy result.
- SelectMDx for Prostate Cancer is a non-invasive urine test to help improve the identification of men at risk for clinically significant cancer being considered for an initial biopsy.